[1]Sanai FM, Keeffe EB.Liver biopsy for histological assessment:Thecase against[J].Saudi J Gastroenterol, 2010, 16 (2) :124-132.
|
[2]Kanamoto M, Shimada M, Ikegami T, et al.Real time elastographyfor noninvasive diagnosis of liver fibrosis[J].J Hepatobiliary Pan-creat Surg, 2009, 16 (4) :463-467.
|
[3]Weigand K, Weigand K.Percutaneous liver biopsy:retrospectivestudy over 15 years comparing 287 inpatients with 428 outpatients[J].J Gastroenterol Hepatol, 2009, 24 (5) :792-799.
|
[4]van der Poorten D, Kwok A, Lam T, et al.Twenty-year audit ofpercutaneous liver biopsy in a major Australian teaching hospital[J].Intern Med J, 2006, 36 (11) :692-699.
|
[5]Landen S, Ballet T, Bollars P, et al.Liver tuberculosis mistakenfor malignancy.The role of needle biopsy[J].Acta GastroenterolBelg, 2010, 73 (2) :278-279.
|
[6]Karamshi M.Performing a percutaneous liver biopsy in parenchymal liv-er diseases[J].Br J Nurs, 2008, 17 (12) :746-752.
|
[7]范平, 江军, 冯晓峰, 等.500例经皮肝穿刺活检并发症分析[J].中华消化杂志, 2004, 24 (7) :426.
|
[8]Pinelo E, Presa J.Outpatient percutaneous liver biopsy:still a good op-tion[J].Eur J Intern Med, 2009, 20 (5) :487-489.
|
[9]Schwarz KB, Zellos A, Stamato L, et al.Percutaneous liver biopsyin hemophiliac children with chronic hepatitis C virus infection[J].J Pediatr Gastroenterol Nutr, 2008, 46 (4) :423-428.
|
[10]Sterling RK, Lyons CD, Stravitz RT, et al.Percutaneous liver bi-opsy in adult haemophiliacs with hepatitis C virus:safety of outpa-tient procedure and impact of human immunodeficiency virus coin-fection on the spectrum of liver disease[J].Haemophilia, 2007, 13 (2) :164-171.
|
[11]Oshrine B, Lehmann LE, Duncan CN.Safety and utility of liver bi-opsy after pediatric hematopoietic stem cell transplantation[J].Pe-diatr Hematol Oncol, 2011, 33 (3) :e92-97.
|
[12]Wood B, Pearson N, Crisp M, et al.Pseudoaneurysm formation af-ter ultrasound-guided liver biopsy in an obese child[J].SouthMed J, 2009, 102 (4) :432-434.
|
[13]Yeo WT, Tan LK, Dan YY, et al.Delayed bleeding after liver bi-opsy:a dreaded complication[J].Singapore Med J, 2008, 49 (1) :76-80.
|
[14]Pen~a LR, Horn TL, Cross CB.Acute pancreatitis secondary to he-mobilia after percutaneous liver biopsy[J].Therap Adv Gastroen-terol, 2009, 2 (3) :165-168.
|
[15]Padia SA, Baker ME, Schaeffer CJ, et al.Safety and efficacy ofsonographic-guided random real-time core needle biopsy of theliver[J].J Clin Ultrasound, 2009, 37 (3) :138-143.
|
[16]Chahal P, Levy C, Litzow MR, et al.Utility of liver biopsy in bonemarrow transplant patients[J].J Gastroenterol Hepatol, 2008, 23 (2) :222-225.
|
[17]Takamori R, Wong LL, Dang C, et al.Needle-tract implantationfrom hepatocellular cancer:is needle biopsy of the liver always neces-sary?[J].Liver Transpl, 2000, 6 (1) :67-72.
|
[18]Tung WC, Huang YJ, Leung SW, et al.Incidence of needle tractseeding and responses of soft tissue metastasis by hepatocellular car-cinoma postradiotherapy[J].Liver Int, 2007, 27 (2) :192-200.
|
[19]Skladany L, Jarcuska P, Oltman M, et al.Percutaneous biopsy ofthe liver[J].Vnitr Lek, 2003, 49 (8) :679-683.
|
[1] | Dan LIU, Tiantian YAO, Yuhan ZHANG, Guiqiang WANG, Yan WANG. Efficiency and safety of immune checkpoint inhibitors in cancer patients with chronic liver disease: A systematic review[J]. Journal of Clinical Hepatology, 2022, 38(11): 2457-2461. doi: 10.3969/j.issn.1001-5256.2022.11.005 |
[2] | FU YiMing, JI Dong, SHAO Qing, LI ZhongBin, WANG ChunYan, CHEN SongHai, CHEN GuoFeng. Association of liver stiffness measurement and serum biochemical parameters with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2020, 36(11): 2473-2477. doi: 10.3969/j.issn.1001-5256.2020.11.015 |
[3] | Chen JiaCheng, Chen XiaoJing, Zhuang ChunYu, Liu FuJin, Luo ShiShi, Chen Liang, Wu JinCai, Zhou KaiLun. A case of splenectopia in the liver[J]. Journal of Clinical Hepatology, 2020, 36(5): 1131-1133. doi: 10.3969/j.issn.1001-5256.2020.05.040 |
[4] | HAO DaAng, LIU Ye, YAN XueBing. An etiological analysis of liver diseases with negative hepatotropic virus[J]. Journal of Clinical Hepatology, 2020, 36(12): 2735-2739. doi: 10.3969/j.issn.1001-5256.2020.12.019 |
[5] | He ZhiYing, Wang BingQiong, You Hong. Clinical application of quantitative assessment of liver fibrosis based on pathology and imaging technology[J]. Journal of Clinical Hepatology, 2018, 34(1): 20-23. doi: 10.3969/j.issn.1001-5256.2018.01.003 |
[6] | Wu Bin, Shen YiYu, Chen XuJian, Zhong Hai, Wang XiaoGuang, Song ZhengWei, Zhong ZhengXiang. Value of endoscopic ultrasonography in diagnosis of pancreatic space-occupying diseases[J]. Journal of Clinical Hepatology, 2018, 34(8): 1723-1727. doi: 10.3969/j.issn.1001-5256.2018.08.026 |
[7] | Wu DongBo, Chen EnQiang, Bai Lang, Tang Hong. Liver biopsy and related techniques in pathological diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2295-2299. doi: 10.3969/j.issn.1001-5256.2018.11.006 |
[8] | Wen HongXu, Xue DiQiang, Du HongWei, Ming YuZhen. Common bile duct wall puncture and biopsy guided by endoscopic ultrasonography in diagnosis of common bile duct malignant tumor:a case report[J]. Journal of Clinical Hepatology, 2017, 33(7): 1346-1348. doi: 10.3969/j.issn.1001-5256.2017.07.031 |
[9] | Jiang LiNa, Zhao JingMin. Role of histological evaluation of the liver in clinical practice and research on nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2303-2306. doi: 10.3969/j.issn.1001-5256.2017.12.009 |
[10] | Sun HaiYing, Wang YaJun, Wang Ming, Zhang ShuQin, Lyu ShengJun, Chen Hui. Liver biopsy results of chronic HBV carriers aged above 40 years: an analysis of 442 cases[J]. Journal of Clinical Hepatology, 2017, 33(8): 1479-1482. doi: 10.3969/j.issn.1001-5256.2017.08.013 |
[12] | Li Peng, Ding HuiGuo. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis[J]. Journal of Clinical Hepatology, 2015, 31(8): 1193-1197. doi: 10.3969/j.issn.1001-5256.2015.08.003 |
[13] | Yang Rui, Zhang YaPing, Wang XinHong, Zhu Bin, Zhang GuangWen. Analysis of predictors of liver injury stage in chronic HBV infection patients with ALT levels lower than 2 × ULN[J]. Journal of Clinical Hepatology, 2014, 30(9): 895-898. doi: 10.3969/j.issn.1001-5256.2014.09.014 |
[14] | Cheng XiaoJing, Lu Wei, Hou Wei, Wang ChunYan, Liu YongGang, Wang JinSheng, Meng Chao. Diagnostic value of FibroTest combined with FibroScan for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(5): 424-427. doi: 10.3969/j.issn.1001-5256.2014.05.010 |
[15] | Zhu JuanJuan, Liu Qin, Mu Mao, Chen Jia, Wang NiuNiu, Li JunLi. One case of hepatic amyloidosis[J]. Journal of Clinical Hepatology, 2014, 30(8): 805-806. doi: 10.3969/j.issn.1001-5256.2014.08.028 |
[16] | Chen Nian, Ke Liu, Jiang ZhongSheng, Wen XiaoFeng, Su MingHua. Relationship between HBV DNA level and pathological changes of liver tissue in HBeAg-negative patients with chronic HBV infection[J]. Journal of Clinical Hepatology, 2013, 29(6): 438-440. |
[17] | Wu YuZhuo. Correlation analysis of quantitative HBsAg and liver histological features of HBeAg-negative chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 923-925. |
[18] | Sha XiuJuan, Xin GuiJie, Jin MeiShan, Chi TouMei, Niu JunQi. Pay much attention to the clinical application of pathological examination of liver biopsy in the diagnosis and treatment of liver disease[J]. Journal of Clinical Hepatology, 2012, 28(3): 223-226. |
[19] | Shen MeiRong, Li ZhongPing, Ding XiaoHong, Chu Feng, Hu DeChang. Clinical significance of liver biopsy in diagnosis and treatment of liver disease[J]. Journal of Clinical Hepatology, 2012, 28(7): 545-547. |